A Noninvasive Assessment of Pulmonary Perfusion Abnormality in Patients With Primary Pulmonary Hypertension
- 1 March 2001
- Vol. 119 (3) , 824-832
- https://doi.org/10.1378/chest.119.3.824
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol InfusionJournal of the American College of Cardiology, 1997
- Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary HypertensionCirculation, 1997
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- Pathology and pathophysiology of primary pulmonary hypertensionThe American Journal of Cardiology, 1995
- Hemodynamic correlates of exercise function in patients with primary pulmonary hypertensionJournal of the American College of Cardiology, 1991
- Control of ventilation during exercise in patients with central venous-to-systemic arterial shuntsJournal of Applied Physiology, 1988
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987
- A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertensionAmerican Heart Journal, 1985
- Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.Circulation, 1982